Nath Bio-Genes (India) Limited, a active public limited company, was established on 14 July 1993 in Aurangabad, Maharashtra, India. Engaging in seed production & distribution within the agriculture, forestry, fishing sector, it holds CIN: L01110MH1993PLC072842. Registered under ROC Roc Mumbai. it is listed on BSE: 537291 and NSE: NATHBIOGEN. It has an authorized capital of ₹21.00 Cr and a paid-up capital of ₹19.00 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹301.85 Cr and a net worth of ₹573.35 Cr. Employing 417 professional, Its leadership includes Vadla Nagabhushanam (Director), Akash Nandkishor Kagliwal (Director), Jeevanlata Nandkishor Kagliwal (Director). Past directors included Sweta Akash Kagliwal, Pramod Kumar Gupta, Vadla Nagabhushanam. It holds ₹114.10 Cr open charges and ₹183.20 Cr settled loans. Its latest AGM occurred on 22 August 2025, with the balance sheet filed on 31 March 2025. It is based at Nath House Nath Road, Aurangabad, Maharashtra, 431005.
L01110MH1993PLC072842
072842
14 July 1993
₹21.00 Cr
₹19.00 Cr
Roc Mumbai
Listed (BSE: 537291, NSE: NATHBIOGEN)
Active
Explore comprehensive insights into Nath Bio-Genes (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vadla Nagabhushanam | Director | 07 Nov 2020 | Current |
| Akash Nandkishor Kagliwal | Director | 22 Apr 2023 | Current |
| Jeevanlata Nandkishor Kagliwal | Director | 30 May 2019 | Current |
| Madhukar Dhondiraj Deshpande | Director | 10 Feb 2021 | Current |
| Hitesh Rajnikant Purohit | Director | 30 Mar 2022 | Current |
| Satish Laxminarayan Kagliwal | Managing Director | 29 Mar 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Aug 2015 | Past |
| Pramod Abcsdd | Nominee Director | 03 Oct 2016 | Past |
| Pramod Abcsdd | Additional Director | 27 Aug 2021 | Past |
| Pramod Abcsdd | Director | 10 Oct 2012 | Past |
| Pramod Abcsdd | Director | 10 Oct 2012 | Past |
| Pramod Abcsdd | Additional Director | 10 Aug 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nath Bio-Genes (India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.72% increase. The company also saw a substantial improvement in profitability, with a 152.22% increase in profit. The company's net worth moved up by a moderate rise of 5.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nath Bio-Genes (India) had a promoter holding of 45.59% and a public holding of 54.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,140,950,000.00
₹1,832,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2025 | Others | ₹5.00 Cr | Open |
| 13 Jun 2025 | Others | ₹8.00 M | Open |
| 21 Jun 2024 | Axis Bank Limited | ₹1.03 M | Open |
| 03 Apr 2024 | Hdfc Bank Limited | ₹5.78 M | Open |
| 06 Mar 2024 | Hdfc Bank Limited | ₹3.15 M | Open |
Explore comprehensive loan charge details -
Nath Bio-Genes (India) has a workforce of 417 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nath Bio-Genes (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nath Bio-Genes (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nath Bio-Genes (India) Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101141509 was registered on 30 Jul 2025. was completed.
Progress on Payal Dilipkumar Jain was appointed as a Additional Director was appointed as a Additional Director on 11 Jul 2025 & has been associated with this company since 5 months 16 days . was documented.
The activity A charge with Others amounted to Rs. 0.80 Cr with Charge ID 101139826 was registered on 13 Jun 2025. was completed.
The activity Nath Bio-Genes (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on Amol Arunrao Gupta was appointed as a Cfo was appointed as a Cfo on 03 Jan 2025 & has been associated with this company since 11 months 22 days . was documented.
The CIN of Nath Bio-Genes (India) Limited is L01110MH1993PLC072842.
Nath Bio-Genes (India) Limited is headquartered at Nath House Nath Road, Aurangabad, Maharashtra, 431005.
Nath Bio-Genes (India) Limited was incorporated on 14 July 1993.
The current directors of Nath Bio-Genes (India) Limited are
The primary industry of Nath Bio-Genes (India) Limited is Agriculture, Forestry, Fishing.
Nath Bio-Genes (India) Limited is listed. It is listed on BSE: 537291 and NSE: NATHBIOGEN.
The authorized capital of Nath Bio-Genes (India) Limited is ₹21.00 Cr, and the paid-up capital is ₹19.00 Cr.
The compliance status of Nath Bio-Genes (India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX